About Hemophilia Type B (Factor IX Deficiency)

Overview
Hemophilia Type B, also known as Christmas disease, is a rare bleeding disorder that is primarily inherited. It occurs when there is a deficiency of clotting factor IX, which is necessary for proper blood clotting. Hemophilia B affects approximately 1 in 25,000 newborn males and fewer female newborns. It was named after Stephen Christmas, who had the condition and was mentioned in the first medical literature about it in 1952. People with Hemophilia B do not bleed faster than those without the condition but have prolonged bleeding. Diagnosis involves various tests, including a complete blood count, clotting factor IX check, and a review of symptoms and medical history. Treatment typically involves preventing or managing bleeding episodes by replacing clotting factor IX or special plasma transfusions using donated blood, newer therapies with monoclonal antibodies, and lifestyle and self-care changes. It's important to consult with a healthcare professional for diagnosis and treatment options.
Causes and Risk Factors

Hemophilia B is primarily caused by a genetic variation in the F9 gene on the X chromosome. This gene alteration leads to a deficiency or impaired function of clotting factor IX, which is necessary for blood clotting. In very rare instances, it can develop later in life as an autoimmune disease where the body produces antibodies that attack factor IX. The pathophysiology of Hemophilia B involves difficulties in forming blood clots to help stop bleeding.

The main risk factor for Hemophilia B is family history of the condition:

  • Genetic inheritance: Hemophilia B is an X-linked recessive disorder. This means the gene mutation that causes Hemophilia B is only on the X-chromosome. Recessive means that for people with two X-chromosomes, both X-chromosomes must have the gene defect.
  • Gender: Males are more likely to be affected by Hemophilia B since they have one X chromosome and one Y chromosome. For females to have inherited Hemophilia B, both X chromosomes must have the gene defect.

For the rare cases of acquired Hemophilia B, risk factors may include having automimmune conditions such as rheumatoid arthritis and inflammatory bowel disease.

It's crucial for individuals with a family history of hemophilias or other bleeding disorders to discuss their risks with a healthcare professionals to obtain individualized advice regarding their risks and recommended testing for diagnosis.

Symptoms

Symptoms of Hemophilia B include:

  • Frequent nosebleeds.
  • Long episodes of bleeding or pain and swelling following cuts or minor injuries.
  • Excessive bleeding after cuts, injuries, dental procedures, or surgery.
  • Easy bruising or hematoma (blood buildup) in the skin or muscles
  • Pain and swelling in the joints
  • Blood in the urine or stool.

It's important to note that the severity of Hemophilia B can vary from mild to severe, depending on the level of clotting factor IX in the blood and progression to complications, such as hemophilic arthropathy (joint disease). People with symptoms of Hemophilia B should consult with a healthcare professional for an accurate diagnosis and personalized advice.

Diagnosis

To diagnose Hemophilia Type B, the following examinations, tests, and procedures are commonly performed:

  • Medical history: The doctor will ask about your symptoms related to bruising and bleeding, pain especially in the joints or muscles, and about family members who have hemophilia or a bleeding disorder.
  • Physical Exam: The healthcare provider will look for physical signs of bleeding such as bruised and swelling in the muscles, joints and other parts of the body.
  • Blood Tests: These tests measure the levels and activity of clotting factors. They can help confirm a diagnosis of Hemophilia B and determine the severity. Common blood tests include factor IX activity, platelet count, fibrinogen level, prothrombin time, and partial thromboplastin time (PTT).
  • Genetic Testing: This involves using blood, saliva, or other tissue samples to identify changes in genes, chromosomes, or proteins. Genetic testing can confirm or rule out a suspected genetic disease and determine the likelihood of passing it on to children.
  • Other examinations, tests, or procedures may be recommended based on the individual situation. For example, imaging studies such as X-rays or MRI may be recommended to enable the doctor to look inside the body for bleeding or complications like joint problems. The type of imaging study depends on symptoms and the body part being examined.

It is important to consult with your healthcare provider about which specific examinations, tests, and procedures are appropriate for your individual situation.

Treatment Options

The goals of treatment for Hemophilia B are to prevent and manage bleeding episodes, lower the risk of complications, and improve quality of life. Treatment may include:

  • Prophylaxis to prevent or reduce the number of bleeding episodes or episodic. This involves using medication, such as Factor IX, on a regular basis to help maintain adequate levels of clotting factor in the blood.
  • Episodic treatment to manage bleeding episodes. This involves using medication or other treatments when bleeding occurs.

Treatments may include:

  • Factor IX replacement therapy: This is the primary treatment option for Hemophilia B. It involves replacing the deficient clotting factor IX through regular intravenous infusion. Factor IX concentrates are infused to restore clotting ability and prevent bleeding.
  • Marstacimab: This is a newer, non-factor treatment for Hemophilia A and Hemophilia B. It is a monoclonal antibody that prevents inhibition of Factor Xa, which enables clotting by bypassing Factor VIII or Factor IX in the normal clotting cascade.
  • Gene Therapy: Gene therapies are one of the newest treatments for hemophilia. Gene therapy involves infusing a medication with the gene needed to produce clotting factor. Currently available gene therapies for Hemophilia B are:
    • Etranacogene dezaparvovec: This gene therapy is approved for adults with Hemophilia B.
    • Fidanacogene elaparvovec: This gene therapy is approved for adults with Hemophilia B.
  • Aminocaproic acid: This medication is an antifibrinolytic, which prevents the breakdown of blood clots. It may be recommended before surgery or dental procedures to preserve blood clots and prevent excessive bleeding.
  • Physical therapy: In severe cases where Hemophilia B has caused joint damage, physical therapy may be recommended for rehabilitation and pain management.

Lifestyle and Self-Care

In addition to medication and therapeutic procedures, there are certain lifestyle behavior changes that can help manage Hemophilia B:

  • First aid: Pressure bandages and ice packs are recommended to manage minor cuts and small areas of bleeding.
  • Avoid medications that may increase risk of bleeding: This includes blood thinning medications, aspirin, and non-steroidal anti-inflammatory drugs (NSAIDs). Consult a healthcare professional before starting new medications.
  • Avoid activities that may cause injury or bleeding: Individuals with hemophilias should avoid activities that have a high risk of injury or bleeding, such as contact sports or activities that involve sharp objects.
  • Regular check-ups: Regular check-ups with healthcare providers are important for monitoring the condition and adjusting treatment as needed.
  • Dental care: Dental procedures should be performed with caution, and specific measures may be taken to ensure minimal bleeding during dental treatments.
  • Get vaccinations: The Centers for Disease Control and Prevention (CDC) recommends that people with hemophilia receive recommended vaccines. Be sure the healthcare professional administering the vaccine is aware you have hemophilia and uses the smallest gauge needle possible. Apply pressure or ice for 3-5 minutes after injection to reduce risk of bleeding.

Overall, the goal of treatment for Hemophilia B is to prevent bleeding episodes, manage pain, and improve overall quality of life for individuals living with these conditions. Treatment plans will vary depending on the specific type and severity of hemophilia, and should be discussed with a healthcare provider.

Medication dosing may be affected by many factors. Check with your health care professional about dosing for your individual situation. Side effects can occur. Check with your health care professional or read the information provided with your medication for side effect information

What are the treatment options for Hemophilia Type B?

How can I prevent bleeding episodes?

Are there any lifestyle changes I should make to manage my condition?